RESPIRERX PHARMA INC (RSPI) earnings
Quarterly and annual RSPI reports and results, each read against the price at its own news timestamp. Back to the RSPI overview →
3 measured RSPI earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form NT 10-K RespireRx Pharmaceutical For: Dec 31 | SEC filing · Form NT | +0.00% | -10.00% | |
| Form 10-Q RespireRx Pharmaceutical For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +10.00% | |
| Form NT 10-Q RespireRx Pharmaceutical For: Sep 30 | SEC filing · Form NT | +0.00% | +0.00% |
Keep exploring
More RSPI: analyst actions → · SEC filings → · RSPI overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Evelo Biosciences, Inc. (EVLO) | 28 | -3.02% | 36% |
| Nu-Med Plus Inc. Com (NUMD) | 28 | 0.00% | 41% |
| Axim Biotechnologies, Inc (AXIM) | 27 | 0.00% | 16% |
| Crescita Therapeutics Inc (CTX_TSE) | 27 | 0.00% | 22% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.